An integrated, specialty healthcare company.

Concordia is an international specialty pharmaceutical company focused on generic and legacy pharmaceutical products. Concordia trades on the NASDAQ Global Select Market® under the symbol CXRX, and on the Toronto Stock Exchange under the symbol CXR.

  • View Stock Information

  • View Stock Information

  • Latest News

  • Downloads

    Information Circular

    Amended Interim Order

    2018 First Quarter Report

    CBCA Interim Order

    CBCA Motion Record Volume 1

    CBCA Motion Record Volume 2

    CBCA Term Sheet

    CBCA Subscription Agreement

    CBCA Support Agreement

    Disclosure Materials

    CBCA Recapitalization Document – Preliminary Interim Order

    CBCA Recapitalization Document – Motion Record Volume 1

    CBCA Recapitalization Document – Motion Record Volume 2

    Concordia International DELIVER Presentation

    DELIVER Fact Sheet

    2017 Annual Report

    2017 Year-End MD&A

    2017 Third Quarter Report

    2017 Second Quarter Report

    2017 First Quarter Report


    View Financials

  • Events

  • Investor Relations

    For investor-related queries, please contact:

    1 905 842 5150